Prevention of coronary ischemic events after PCI can be effectively achieved with dual antiplatelet therapy (DAPT) with aspirin and a P2Y12 inhibitor [4,5,6], while long-term use of OAC provides protection against cerebrovascular and systemic embolism in patients with AF [2]. The gene discussed is P2RY12; the disease is atrial fibrillation.